Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

L-Dihydroorotic Acid

    • Product Name L-Dihydroorotic Acid
    • Alias Dihydroorotic acid
    • Einecs 256-020-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    788637

    Productname L-Dihydroorotic Acid
    Casnumber 5988-61-6
    Molecularformula C5H7NO4
    Molecularweight 145.11 g/mol
    Appearance White to off-white solid
    Meltingpoint 190-194 °C (dec.)
    Solubility Soluble in water
    Purity Typically >98%
    Iupacname (S)-4,5-dihydroorotic acid
    Storagetemperature 2-8 °C
    Synonyms L-2,6-Dioxotetrahydropyrimidine-4-carboxylic acid

    As an accredited L-Dihydroorotic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing L-Dihydroorotic Acid is supplied in a 25g amber glass bottle with a tamper-evident seal, labeled with product information.
    Shipping L-Dihydroorotic Acid is shipped in tightly sealed containers to protect from moisture and contamination. Packages are labeled according to chemical safety regulations. The product is transported at ambient temperature and handled with appropriate personal protective equipment. Shipping complies with local, national, and international chemical transport regulations to ensure safe delivery.
    Storage L-Dihydroorotic Acid should be stored in a tightly closed container, protected from light and moisture. Keep the substance at room temperature, preferably between 15–25°C (59–77°F), and in a well-ventilated, dry area away from incompatible substances such as strong oxidizers. Ensure the storage area is clearly labeled and follow safety protocols to prevent contamination or accidental exposure.
    Application of L-Dihydroorotic Acid

    Applications of L-Dihydroorotic Acid in Industrial Manufacturing

    L-Dihydroorotic Acid plays a defined role in several advanced chemical manufacturing sectors, where its properties directly benefit complex synthetic routes and strict formulation processes. Our production protocols ensure batch-to-batch consistency, supporting critical compliance and efficiency requirements for regulated industries. Explore how end-users deploy this material in distinct industrial scenarios below.

    1. Pharmaceutical API Synthesis – Pyrimidine Intermediates

    Pharmaceutical producers widely employ this ingredient as a key intermediate within the pyrimidine biosynthesis pathway, where stringent purity and traceability drive demand for validated sourcing. During the multi-stage production of specific nucleosides and antiviral actives, it integrates seamlessly at the heterocycle assembly step, influencing downstream yield and impurity profiles. Quality control teams rely on its predictable solubility profile for effective process validation, safeguarding regulatory filing consistency for finished APIs.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • United States Pharmacopeia (USP) Reference Standards for intermediates
    • European Pharmacopoeia guidelines for API manufacturing
    • FDA 21 CFR Parts 210/211 (for cGMP bulk drugs)

    Typical usage ratio

    • Commonly 0.5–2.0 molar equivalents per pyrimidine ring-forming step, adjusted for route efficiency and targeted impurity thresholds

    Downstream process integration

    • Introduced after base scaffold preparation during condensation or cyclization to form dihydroorotate moieties, typically in semi-automated reactor trains with real-time analytical QC

    Final product types

    • Synthesized nucleoside antivirals (e.g., lamivudine, emtricitabine precursors)
    • Oncology drug intermediates
    • High-purity pyrimidine derivatives for further esterification or hydrolysis

    2. Biotechnological Fermentation Nutrient Additive

    Industrial biotechnology facilities add this compound to microbial fermentation systems for optimized growth of engineered microbial strains synthesizing nucleotides and biopharmaceutical agents. By supporting specified metabolic pathways, the additive enhances biomass generation and selective target accumulation under rigorously controlled fed-batch or continuous culture regimes. Plant process engineers monitor dosage and feeding intervals to match dynamic culture requirements, minimizing downstream purification burdens.

    Industry compliance standards

    • ISO 9001:2015 for production traceability
    • Current Good Manufacturing Practice (cGMP) microbial fermentation guidelines
    • European Food Safety Authority (EFSA) specifications for fermentation auxiliaries (when used in GRAS applications)

    Typical usage ratio

    • Generally 0.05–0.15% (w/v) of fermentation broth, tuned by initial cell density and scale-up model requirements

    Downstream process integration

    • Dosed automatically with other nutrient solutions at inoculation phase and as a controlled-feed through logarithmic growth, using sterilized feed systems and monitored by HPLC

    Final product types

    • Microbially synthesized nucleotides (e.g., uridine, cytidine)
    • Starter cultures for nucleotide production
    • Recombinant biotherapeutic intermediates reliant on pyrimidine pathways

    3. Fine Chemical Synthesis – Specialty Heterocycle Production

    Producers of advanced fine chemicals utilize L-Dihydroorotic Acid as a foundational component in constructing diverse heterocyclic frameworks, particularly for high-performance electronic and agricultural intermediates. In these contexts, control over input profiles optimizes chromatographic yields and downstream stability, and its reliable supply supports batch reproducibility in scale-up environments. QC inspectors track spectroscopic purity and residue profiles from delivery to post-reaction workup.

    Industry compliance standards

    • ISO 9001:2015 process documentation and lot traceability (fine chemical manufacturing)
    • REACH Regulation (EC) No 1907/2006 for chemical safety
    • EFfCI Good Manufacturing Practice Guide for Cosmetic Ingredients (when relevant to downstream)

    Typical usage ratio

    • Ranged from 0.7–2.5 molar equivalents per target heterocycle, defined by multi-step synthetic yield optimization and impurity minimization strategies

    Downstream process integration

    • Fed at initiation or mid-stage of heterocycle assembly, often under anhydrous or inert gas conditions to ensure selective ring closure and minimize by-product formation; use monitored by in-line FTIR or NMR

    Final product types

    • Precursors for advanced active agricultural ingredients with functionalized ring systems
    • Functional intermediates for electronic chemical manufacturing (e.g. photoresists, specialty resins)
    • Key building blocks for further derivatization in specialty R&D pipelines

    4. Active Pharmaceutical Ingredient Quality Control Reference Material

    Quality control laboratories at API manufacturing sites routinely use authenticated samples of L-Dihydroorotic Acid as a reference material in compendial and non-compendial analytical testing. This application supports ongoing process validation and ensures regulatory audit readiness, particularly for facilities producing nucleoside analogues or materials subject to tight impurity profile limits. Reference-grade material assures analytical system suitability checks on LC-MS, NMR, and HPLC platforms, reinforcing batch release decisions.

    Industry compliance standards

    • USP General Chapters – Reference Standards
    • ICH Q2(R1) – Validation of Analytical Procedures
    • European Pharmacopoeia, section on reference substances

    Typical usage ratio

    • Prepared at 1–10 ppm levels as system suitability/quantitation standards, adjusted by instrument calibration range and matrix type

    Downstream process integration

    • Deployed at each drug substance batch release and for ongoing process verification; prepared in dedicated QC sample rooms immediately prior to HPLC or LC-MS runs

    Final product types

    • Reference standard sample kits for internal and external QC
    • Validated API lot release documentation for regulatory submission
    • Archival control samples conforming to ICH/Pharmacopoeia requirements
    Free Quote

    Competitive L-Dihydroorotic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    L-Dihydroorotic Acid: A Direct Manufacturer’s Perspective

    Understanding the Product at its Core

    L-Dihydroorotic Acid stands as a niche intermediate in the world of fine chemicals. As a chemical manufacturer who has spent years working with heterocyclic compounds, I see its production as a precise art. Most know the molecule for its role in pyrimidine biosynthesis, critical for pharmaceutical applications and research labs. Yet, sitting on the production floor, you notice details often missed by those who only handle it on paper. Batch-to-batch purity can dip if even one parameter shifts. L-Dihydroorotic Acid, chemical formula C5H6N2O4, is sensitive to humidity and light; we keep it sealed in amber glass or foil-lined drums, always under nitrogen atmosphere when stored longer than a week.

    The solid, fine powder or crystalline flakes are off-white, although slight yellowing doesn’t necessarily indicate decomposition—impurities often drive the shift. Yet customers in regulated spaces like GMP pharma operations expect almost colorless material, so we run an additional recrystallization step for those clients, accepting reduced yield for higher purity. HPLC checks, along with water content (Karl Fischer) and residual solvent analysis, are done for every lot. Many labs request a typical assay above 99.0%, but for some research or industrial use cases, slightly lower concentrations meet their requirements.

    How Specification Choices Evolved on the Shop Floor

    A decade back, specifications followed pharmacopeial monographs almost blindly. Through repeated runs and scale-ups, I realized many methods focus too hard on chasing vanishingly small impurities. Reproducibility trumps chasing theoretical minimums, especially when customers actually require a material that behaves predictably, not just a number on a page. We focus on controlling crystal size with careful temperature ramps at the precipitation stage; this prevents problematic cake formation during filtration or blockage in feed lines for those using L-Dihydroorotic Acid in automated continuous reactors.

    Specs like particle size distribution and bulk density sound abstract, but these numbers have practical impacts. Years ago, a batch shipped to a peptide manufacturer jammed their feeder due to an overlooked agglomeration. Since then, we use vibration screens and deliver particle size certificates on request. No batch leaves the plant without a retention sample kept for at least two years. By comparing retained samples, we catch shifts in the process—maybe the filter cloths wore out quicker, or a new batch of solvent altered crystallization. Attention to these details separates a chemical manufacturer from a mere compounder.

    How Usage Drives Critical Choices

    Clients run the spectrum: pharmaceutical companies synthesizing barbiturates or antitumor compounds, bioengineering outfits optimizing metabolic pathways, academic labs tracing enzyme activity. Depending on end use, they ask for differing lot sizes—from multi-kilo industrial bags to 500-gram bottles for R&D teams. Some need documentation for additives used during synthesis, since trace presence of certain metals or organic bases, even in the low ppm range, might poison enzymes or disrupt downstream reactions. We run optional ICP-MS scans for heavy metals and deliver signed statements when needed.

    L-Dihydroorotic Acid dissolves well in hot water, slightly less in alcohols. Solubility, often considered a line in the spec sheet, proves crucial when scaling lab syntheses to kilo-scale production. At larger scale, insufficient stirring means undissolved fractions remain, hurting yield and causing batch failures. Years ago, trouble-shooting a long-term customer’s issues with incomplete dissolution in their bioreactor led us to optimize particle distribution. The so-called invisible quality often makes all the difference between frustration and smooth operation.

    Tangible Differences from Other Organic Acids

    From a chemist’s bench, L-Dihydroorotic Acid might seem a sibling to several other dihydro derivatives: Dihydroorotate (mono-anion), or a range of racemic and D-forms. In manufacturing practice, these differences drive equipment, safety, and handling changes through the entire workflow. The L-enantiomer, aside from having slightly higher melting points and distinct optical rotation, matches the configuration needed by most pharmaceutical targets. Improper enantiomeric purity can throw off bioactivity in enzyme studies or biological synthesis, so we monitor chiral purity by polarimetry and chiral HPLC.

    Relative to orotic acid, the parent compound, L-Dihydroorotic Acid is more sensitive to oxidation. Air contact during storage, especially at elevated temperature or high humidity, opens the door to product loss through color change and quenching of activity in enzyme systems. Our process, from quenching the reactor to packaging, emphasizes minimizing oxygen and moisture exposure, selecting containers meant for longer shelf life. Supplying racemic or D-form dihydroorotic acid mostly involves changing the precursor configuration during synthesis. Yet that “simple” switch brings new headaches: mother liquor recycles must remain separate, analytical methods get recalibrated, and waste handling—especially for off-spec enantiomeric excess—shifts regulatory filings and treatment protocols on-site.

    No single chemical turns out the same under every set of process conditions. Orotic acid and its hydrated and oxidized derivatives sometimes crystallize as needles, sometimes plates. L-Dihydroorotic Acid in particular tends towards irregular crystals under quick precipitation; a slower temperature ramp draws out larger flakes, minimizing bulk density but improving filterability. Customers seeking easy handling opt for batches tuned to higher density, so packaging fills more efficiently.

    Focus on Sourcing, Purity, and Documentation

    Running an actual chemical plant puts you face to face with raw material shortages, changing environmental standards, and the endless dance of proof—the paperwork and audit train that supports each shipment. Take sourcing for L-Dihydroorotic Acid. Main feedstocks include dihydrofuran derivatives and nitrile intermediates, themselves subject to price and availability swings. Raw material substitution can shift impurity profiles, so each change triggers a full analytical workup, including NMR spectra and stability tests. No lot reaches the shipping dock without a complete Certificate of Analysis and traceability from precursor chemicals to finished product.

    For customers in pharma or regulated sectors, we deliver regulatory support as part of the shipment—batch tracking, impurity profiles, retest dates, and signed declarations of BSE/TSE status (important for any material used around animal biosynthesis pathways). In-house, the paperwork stack matches the cost of chemicals. Each shipment draws from a batch number keyed to production logs, headspace analysis for residual solvents, and environmental reports for waste treatment compliance. Few on the outside appreciate the complexity behind “assured supply chain;” for us, it means gates, guards, and temperature-monitored warehouses backing every box shipped.

    Environmental and Safety Considerations in Scaling Up

    Every kilogram brought off the final dryer means kilograms of solvent waste, used filter cloth, and acidified mother liquors that demand careful treatment. Years ago, disposal focused simply on neutralizing waste and sending it off-site. Audits and stricter rules demanded we recycle solvents where purity allowed, optimizing reaction workups to minimize total volume. Recovered methanol or ethanol, re-distilled on site, now runs back into our system, and condensate quality is tracked alongside finished product.

    Dust control provides another day-to-day challenge. Though L-Dihydroorotic Acid isn’t classed as particularly hazardous, fine particles irritate skin or lungs, especially in confined spaces. Operating the granulators and filters safely means sealed systems, explosion-proof instrumentation, and regular air quality checks. We provide operators with fitted gloves and face shields; process improvements over the years have dropped our lost-time injuries and brought insurance relief as well as peace of mind.

    Shipping regulations always chase reality, never quite catching up. Packing L-Dihydroorotic Acid for air or sea transit means verifying moisture barriers, adding desiccant bags, and confirming containment. Customs inspections, if prompted, look for documentation of synthetic route, origins of the precursor material, and full chain of custody. For a manufacturer, keeping this documentation current takes as much effort as the actual synthesis.

    Quality by Design Over Quality by Hindsight

    Decades ago, chemists mixed reactions with paddles or open steam jackets, “feeling” the endpoint by color and smell. Now, process analytical technology brings in-line probes, real-time HPLC, and digital tracking. We design reactions to avoid hazardous intermediates, and set process limits—not just because regulators demand it, but because product consistency drives repeat customer orders. Predictable thermal ramps, controlled agitation, and validated laboratory analytics make our L-Dihydroorotic Acid worthy of demanding uses.

    We learned through experience that identifying problems during preliminary small-scale runs beats chasing lost yield or out-of-spec batches at kilo scale. For sensitive applications—such as fermentation feedstocks or pharma APIs—customers ask for added documentation. Our analytical labs run detection down to low ppm for common metals, and can expand to a broader suite as needed. This flexibility comes from strong laboratory partnerships, not just internal setups.

    Customers often ask about shelf life and storage recommendations. Our internal testing shows sealed, nitrogen-packed containers keep L-Dihydroorotic Acid within specification for up to two years at 5–10°C. Once opened, stability depends on lab practice—humid air and repeated exposure accelerate breakdown, though usually with a color shift as a visible cue.

    Closing the Loop: Supporting Users, Not Just Selling Chemical

    Years in manufacturing bring constant feedback. A peptide chemist reported filtration issues; we adjusted particle size. A bioengineering firm found trace iron; we sourced purer water and installed additional filtration upstream. Each complaint flagged ways to tune processes to changing user needs—a step beyond selling a chemical, building partnerships with technical teams.

    L-Dihydroorotic Acid links production lines, R&D projects, and new molecular designs. In direct manufacturer-to-customer communication, you learn what matters for each use, then change the process—not just the paperwork—to match. We welcome direct technical inquiries because actual usage sometimes reveals needs unseen in any specification or regulatory guide.

    Changes to scale, regulatory rules, or downstream applications have shaped our working practices more than any external trend. We invest in process improvement and honest reporting. Each drum and bottle pulled from our lines passed not just through reactors and filters, but through conversations between engineers, lab techs, and end-users. Chemical manufacturing at this level never stops learning or improving—each shipment a promise to do the job right again and again.

    Looking Forward: Challenges and Opportunities in L-Dihydroorotic Acid Production

    Markets pivot fast. Tightened pharma standards, green chemistry mandates, or shifts in bioprocessing create new demands. We face challenges in finding reliable raw materials or in reducing the carbon footprint of high-purity production. Years of experience convince me that flexibility means survival; our team stays close to advances in purification technology and regulatory affairs, so we’re ready to adapt formulations, batch sizes, or logistics as the next request lands.

    Yet for all the technical challenges—analytical puzzles, purity targets, logistics hurdles—manufacturing L-Dihydroorotic Acid is about serving real-world science and medicine. Pharmaceutically active ingredients, research programs, and bioengineering all depend on the quiet reliability of well-made chemicals. By keeping close to users and responding with substance, not just slogans, we keep making better batches and solving tomorrow’s challenges before they land.